L-valine/Record

Papers screened

Screened: 781
Admitted: 1
Discarded: 749
Not read: 31

37 queries

pipeline:batch
clinicaltrials.gov intr search: query.intr=L-valine
cited by PMID:21959306 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:23712359 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:29391418 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:29983607 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:30621276; efetch/papersFor returned no usable record
cited by PMID:30621276; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:30621276 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:30999554; efetch/papersFor returned no usable record
cited by PMID:30999554; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:34551205; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:36229643 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:36307414; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:36307414; efetch/papersFor returned no usable record
cited by PMID:36307414 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:37178220; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:38093456; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:38599770; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:38651272 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:38849541; efetch/papersFor returned no usable record
cited by PMID:38849541; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:38919004 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:39025852; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:39025852 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:41042673; efetch/papersFor returned no usable record
cited by PMID:41042673; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:42498891; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:42498891 [cited]; about CHEBI:16414 by its own indexing
("valine"[ti]) NOT ("valinomycin"[tiab]) [observational]
cited by PMID:28578427 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:24465919 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:25009784 [cited]; about CHEBI:16414 by its own indexing
cited by PMID:18487480 [rct]; about CHEBI:16414 by its own indexing
cited by PMID:19837138; efetch/papersFor returned no usable record
cited by PMID:19837138; its own chemicals/MeSH/title name no enrolled subject
cited by PMID:19837138 [mechanism]; about CHEBI:16414 by its own indexing

Retrieval query not recorded: 4 of 781 rows

Produced a finding1 paper

PMID:39567688query not recorded2026-09-18

Discarded — the wrong intervention687 papers

PMID:30999554no claim extracted — combination_exposure (single pass)pipeline:batch2026-09-03
PMID:26536628no claim extracted — subject_species_mismatch — DOSED: Isoleucine-proline-proline (IPP) and valine-proline-proline (VPP) lactotripeptides, always administered together in every included trial, Methods: 'involving the consumption of IPP and VPP by Asian adult subjects for longer than 8 days' | Valine-proline-proline (VPP), a milk-derived tripeptide, always co-administered with isoleucine-proline-proline (IPP) as combined lactotripeptides from fermented milk/casein, Abstract and Methodspipeline:batch2026-09-03

Back to L-valine

Discarded — another reason, stated per paper32 papers

PMID:3206383no claim extracted — subject_absent (single pass) — DOSED: peptide histidine valine (PHV), a 27-residue neuropeptide infused intravenously at 2.5-10 pmol/kg/min — not the free amino acid L-valinepipeline:batch2026-09-04
PMID:28321931no claim extracted — cause not determined (one pass only) — measured: seed germination rate and embryo/seed developmental phenotype in Arabidopsis valine-degradation-pathway mutantspipeline:batch2026-09-18
PMID:34461907no claim extracted — cause not determinedpipeline:batch2026-09-18
PMID:38599770no claim extracted — subject_absent (single pass) — DOSED: a valine tRNA-derived fragment (Val-tRF), a small RNA ligand for the archaeal ribosome — not the free amino acid L-valinepipeline:batch2026-09-18
PMID:38849541no claim extracted — subject_absent (single pass) — DOSED: valine aminoacyl-tRNA synthetase (VARS), an enzyme — not the free amino acid L-valinepipeline:batch2026-09-18
PMID:41042673no claim extracted — subject_absent (single pass) — DOSED: a 5' tRNA-derived fragment of tRNA-Val-CAC-2 (tRFValCAC), a small non-coding RNA — not the free amino acid L-valinepipeline:batch2026-09-18
PMID:4280069no claim extracted — cause not determinedpipeline:batch2026-09-18
NCT00386607design×1 — allocation NON_RANDOMIZED -- not randomisedclinicaltrials.gov intr search: query.intr=L-valine2026-09-21
NCT00457626design×1 — allocation NA -- not randomisedclinicaltrials.gov intr search: query.intr=L-valine2026-09-21
NCT00523744design×1 — allocation NON_RANDOMIZED -- not randomisedclinicaltrials.gov intr search: query.intr=L-valine2026-09-21
NCT01365481design×1 — allocation NA -- not randomisedclinicaltrials.gov intr search: query.intr=L-valine2026-09-21
NCT02062645design×1 — allocation NA -- not randomisedclinicaltrials.gov intr search: query.intr=L-valine2026-09-21
NCT02690974design×1 — allocation NA -- not randomisedclinicaltrials.gov intr search: query.intr=L-valine2026-09-21
NCT02887183design×1 — allocation NA -- not randomisedclinicaltrials.gov intr search: query.intr=L-valine2026-09-21
NCT03534180design×1 — allocation NA -- not randomisedclinicaltrials.gov intr search: query.intr=L-valine2026-09-21
PMID:36200804no claim extracted — subject_absent — DOSED: HIBCH deficiency and ECHS1 deficiency patients — genetic disorders impairing valine catabolic enzymes; L-valine itself is not administered or measured as an exposure in this case series | HIBCH deficiency and ECHS1 deficiency — inherited defects in enzymes of valine catabolism; the paper studies genetic-disease phenotype, never administers or measures L-valine itselfpipeline:batch2026-09-27
PMID:39305589no claim extracted — cause not determined (one pass only) — measured: bacterial antibiotic resistance/sensitivity (no CAT:outcome node for microbial antibiotic susceptibility)pipeline:batch2026-09-27
PMID:2859558no claim extracted — subject_absent — DOSED: magnesium ions (Mg2+) and an unnamed NMDA antagonist in rat hippocampal slices, abstract; valine never mentioned | magnesium ions and an NMDA antagonist in rat hippocampal slices; valine is never mentionedpipeline:batch2026-10-05
PMID:19837138no claim extracted — subject_absent — DOSED: NMDA, spermidine, ifenprodil and APV in organotypic rat hippocampal slice cultures; L-valine is never mentioned | NMDA, spermidine, ifenprodil and APV in organotypic rat hippocampal slice cultures (Results); L-valine is never mentionedpipeline:batch2026-10-11
PMID:23121214no claim extracted — subject_absent — DOSED: glutamate plus glycine, L-NAME, paraoxon and DL-AP5 at the rat neuromuscular junction, abstract; L-valine is never mentioned | glutamate plus glycine, DL-AP5, L-NAME and paraoxon at the rat neuromuscular junction (abstract); L-valine is never mentionedpipeline:batch2026-10-11
PMID:2552039no claim extracted — subject_absent — DOSED: D,L-2-amino-5-phosphonopentanoic acid (D,L-AP5), chronic intraventricular infusion in rats, abstract; L-valine is never mentioned | D,L-2-amino-5-phosphonopentanoic acid (D,L-AP5), chronic intraventricular infusion in rats (abstract); L-valine is never mentionedpipeline:batch2026-10-11
PMID:17572151no claim extracted — cause not determined — DOSED: occupational styrene exposure biomarker (styrene oxide adduct on N-terminal valine); L-valine not dosedpipeline:batch2026-10-12
PMID:18425894no claim extracted — subject_absent — DOSED: aciclovir, ganciclovir, valaciclovir (valine ester prodrug of aciclovir), valganciclovir; L-valine itself never dosed | aciclovir, ganciclovir, valaciclovir, valganciclovir antivirals; L-valine itself not given, abstractpipeline:batch2026-10-12
PMID:19167700no claim extracted — subject_absent — DOSED: BDNF Val66Met genotype; no valine compound administered or measured | BDNF Val66Met gene variant; no valine administered, abstractpipeline:batch2026-10-12
PMID:22399073no claim extracted — subject_absent — DOSED: beta2-glycoprotein I Val/Leu247 polymorphism; no valine compound administered or measured | beta2-glycoprotein I Val/Leu247 polymorphism; no valine administered, abstractpipeline:batch2026-10-12
PMID:23399523no claim extracted — subject_absent — DOSED: PRNP rs1799990 methionine/valine genotype; no valine compound administered or measured | PRNP M/V (methionine/valine) gene polymorphism rs1799990; no valine administered, abstractpipeline:batch2026-10-12
PMID:25350717no claim extracted — cause not determined — DOSED: hemoglobin N-terminal valine adducts as exposure biomarkers; L-valine not dosedpipeline:batch2026-10-12
PMID:27777201no claim extracted — subject_absent — DOSED: intradermal methylene blue; oral valaciclovir as background in both arms; L-valine never dosed | methylene blue plus lidocaine intradermally; oral valaciclovir given to both arms; L-valine not given, abstractpipeline:batch2026-10-12
PMID:31234240no claim extracted — subject_absent — DOSED: valbenazine 40-80 mg/day (Methods); L-valine never named or dosed | valbenazine (VMAT2 inhibitor), 40-80 mg/day, Methods; L-valine not givenpipeline:batch2026-10-12
PMID:32569803no claim extracted — cause not determined — DOSED: glycidol exposure biomarker (N-substituted valine adduct in hemoglobin); L-valine not dosedpipeline:batch2026-10-12
PMID:34652883no claim extracted — cause not determined — DOSED: furfuryl alcohol exposure biomarker (N-substituted valine adduct in hemoglobin); L-valine not dosedpipeline:batch2026-10-12
PMID:37759723no claim extracted — cause not determinedpipeline:batch2026-10-12

Discarded — not retrievable13 papers

PMID:5919350no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:30621276; efetch/papersFor returned no usable record2026-09-29
PMID:2194222no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:30999554; efetch/papersFor returned no usable record2026-09-29
PMID:4373244no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:30999554; efetch/papersFor returned no usable record2026-09-29
PMID:670995no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:30999554; efetch/papersFor returned no usable record2026-09-29
PMID:28486583no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:36307414; efetch/papersFor returned no usable record2026-09-29
PMID:28222245no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:38849541; efetch/papersFor returned no usable record2026-09-29
PMID:4308495no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:38849541; efetch/papersFor returned no usable record2026-09-29
PMID:775098no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:38849541; efetch/papersFor returned no usable record2026-09-29
PMID:10973072no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:41042673; efetch/papersFor returned no usable record2026-09-29
PMID:23044802no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:41042673; efetch/papersFor returned no usable record2026-09-29
PMID:36869120no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:41042673; efetch/papersFor returned no usable record2026-09-29
PMID:6249441no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:19837138; efetch/papersFor returned no usable record2026-10-12
PMID:8210177no PMID parsed, abstract under 200 characters, or no record returned by efetchcited by PMID:19837138; efetch/papersFor returned no usable record2026-10-12

Discarded — an endpoint this vocabulary does not hold12 papers

PMID:36307414no claim extracted — no_outcome_node (single pass) — measured: bacterial growth rate / virulence outcome for an amino-acid-catabolism target, genome-scale metabolic model biomass fluxpipeline:batch2026-09-03
PMID:37178220no claim extracted — no_outcome_node (single pass) — measured: hip fracture incidence, Cox/logistic regression hazard or odds ratio per SD increase in circulating valine, ICD-code ascertained (isolated hip site, not the composite non-vertebral site list)pipeline:batch2026-09-03
PMID:16087981no claim extracted — no_outcome_node — measured: valine dietary requirement, breakpoint of 24-h indicator amino acid oxidation and balance (24-h IAAO/IAAB) against valine intake | valine requirement, 24-h indicator amino acid oxidation and balance (24-h IAAO/IAAB) breakpoint with phenylalanine as indicatorpipeline:batch2026-09-04
PMID:1858703no claim extracted — no_outcome_node — measured: valine oxidation, plasma [1-13C]valine tracer infusion | valine oxidation in fasted and fed state, [1-13C]valine continuous intravenous tracer infusionpipeline:batch2026-09-04
PMID:7582676no claim extracted — no_outcome_node — measured: prolactin response to D-fenfluramine challenge, serum PRL concentration | prolactin response to D-fenfluramine challenge, serum PRLpipeline:batch2026-09-04
PMID:38093456no claim extracted — no_outcome_node (single pass) — measured: mitochondrial oxygen consumption rate / ATP production rate in cultured myoblasts, Seahorse extracellular flux analysispipeline:batch2026-09-18
PMID:39025852no claim extracted — no_outcome_node (single pass) — measured: intracellular lipid content in cultured prostate cancer cells, Nile Red / quantitative single-cell imagingpipeline:batch2026-09-18
PMID:38000127claims extracted but the object named resolved to no node — recorded in candidate_nodes (ADR-0070)pipeline:batch2026-09-27
PMID:38881412claims extracted but the object named resolved to no node — recorded in candidate_nodes (ADR-0070)pipeline:batch2026-09-27
PMID:40318256no claim extracted — no_outcome_node — measured: cardiac/cardiomyocyte hypertrophy severity (no CAT:outcome node for cardiac hypertrophy) | pathological cardiac hypertrophy severity in a valine-exposure model (no cardiac hypertrophy outcome node exists)pipeline:batch2026-09-27
PMID:11510866claims extracted but the object named resolved to no node — recorded in candidate_nodes (ADR-0070)pipeline:batch2026-10-05
PMID:32222880no claim extracted — no_outcome_node — measured: myotube Akt phosphorylation ratio pAkt:Akt, western blot, in vitro | insulin signalling, pAkt:Akt ratio by western blot in C2C12 myotubespipeline:batch2026-10-05

Not read yet31 papers

PMID:1595124query not recorded2026-09-01
PMID:27565781query not recorded2026-09-01
PMID:34401958query not recorded2026-09-01
PMID:18201805cited by PMID:21959306 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:18378672cited by PMID:23712359 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:19636327cited by PMID:29391418 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:20399767cited by PMID:29983607 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:29475409cited by PMID:30621276 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:21531985cited by PMID:36229643 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:28321214cited by PMID:36307414 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:35362856cited by PMID:38651272 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:17291655cited by PMID:38919004 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:17582511cited by PMID:38919004 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:18790709cited by PMID:38919004 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:31409769cited by PMID:39025852 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:37084480cited by PMID:39025852 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:34484560cited by PMID:42498891 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:38803448cited by PMID:42498891 [cited]; about CHEBI:16414 by its own indexing2026-09-29
PMID:11548119("valine"[ti]) NOT ("valinomycin"[tiab]) [observational]2026-09-29
PMID:12641182("valine"[ti]) NOT ("valinomycin"[tiab]) [observational]2026-09-29
PMID:15730420("valine"[ti]) NOT ("valinomycin"[tiab]) [observational]2026-09-29
PMID:16174723("valine"[ti]) NOT ("valinomycin"[tiab]) [observational]2026-09-29
PMID:16686261("valine"[ti]) NOT ("valinomycin"[tiab]) [observational]2026-09-29
PMID:9397106("valine"[ti]) NOT ("valinomycin"[tiab]) [observational]2026-09-29
PMID:9630018("valine"[ti]) NOT ("valinomycin"[tiab]) [observational]2026-09-29
PMID:21471363cited by PMID:28578427 [cited]; about CHEBI:16414 by its own indexing2026-10-04
PMID:21572090cited by PMID:28578427 [cited]; about CHEBI:16414 by its own indexing2026-10-04
PMID:15276021cited by PMID:24465919 [cited]; about CHEBI:16414 by its own indexing2026-10-07
PMID:8435071cited by PMID:25009784 [cited]; about CHEBI:16414 by its own indexing2026-10-08
PMID:17586303cited by PMID:18487480 [rct]; about CHEBI:16414 by its own indexing2026-10-12
PMID:2892896cited by PMID:19837138 [mechanism]; about CHEBI:16414 by its own indexing2026-10-12